Bioheart (OTC: BHRT; Twitter: $BHRT)
LifeTech Capital Updates NeoStem (NBS) Strong Buy $4.00 Target
The ProActive Network's PRISM product
FDA Phase III Approval Historical Stock Performance
DARA Bio ($DARA) - KRN5500 article from the Journal of Pain and Symptom Management International
Lazard Capital Markets Research Report on Ventrus Biosciences (NASDAQ: VTUS; Stock Twits; $VTUS)
Leerink Swann Research Report on Ventrus Bio ($VTUS)
UniLife Corporation (NASDAQ: UNIS) @ Cowan
Unilife ($UNIS) - Jefferies Healthcare Conference
Unilife ($UNIS) Investor Presentation - July 2011
Medgenics (NYSE AMEX: MDGN) - Nomura Code Securities Limited, London
Griffin Securities reiterates Unilife Corp ($UNIS) target with $10.50 target
Tonix Presentation November 2011
Unilife ($UNIS) - Prefilled Syringes Issue of OnDrugDelivery
Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions
Misonix (NASDAQ: MSON) Technology and Growth Status Report - May 2011
Vringo Presentation
Rodman & Renshaw - $VTUS May 2011 Update
Medgenics (NYSE AMEX: MDGN) - Maxim Group Research Report
Ensurge, Inc. (OTCBB: ESGI; Twitter: $ESGI)